Therapy

The EMBARK Model of Psychedelic Therapy

June 4, 2024
Featuring: Alex Belser, Ph.D. & Bill Brennan, Ph.D.

In this episode, Kyle interviews Alex Belser, Ph.D. and Bill Brennan, Ph.D.: psychologists, psychedelic researchers, authors, and co-creators of the EMBARK model, a framework for psychedelic therapy.

Subscribe Share

In this episode, Kyle interviews Alex Belser, Ph.D. and Bill Brennan, Ph.D.: psychologists, psychedelic researchers, authors, and co-creators of the EMBARK model, a framework for psychedelic therapy.

When Belser and Brennan worked together at Cybin, they canvassed the field of psychedelic research and saw very little reporting (if any) of the manuals researchers were using. So, they created the EMBARK model as a “big tent” framework – a way to understand what patients were going through from the perspective of six different clinical domains, where the clinician can go deeper into whichever domain is needed based on their specific skill set. The EMBARK model has been used in two randomized controlled trials to date, and its corresponding book, EMBARK Psychedelic Therapy for Depression: A New Approach for the Whole Person (which they co-authored), was released in April through Oxford University Press.

They discuss:

  • The six domains and four ethical care cornerstones that make up EMBARK, as well as the many proposed change mechanisms that come into play
  • Concerns over facilitators stepping aside and letting the medicine do the work: How much of a factor is someone’s presence in the room?
  • How much smaller, “little t” traumas can affect people – trauma doesn’t always come from a single hallmark event
  • The need for facilitators to be trained well (and trauma-informed), as it’s nearly impossible to tell when an adverse outcome is coming

and more!

Links

EMBARK Psychedelic Therapy for Depression: A New Approach for the Whole Person, by Bill Brennan & Alex Belser

EMBARKapproach.com

Alexbelser.com

Centerforbreakthroughs.com

@BillBrennanPhD Linktree

Embarkapproach.com: Open Access

PT413 – Queering Psychedelics, The Dark History of Conversion Therapy, and The EMBARK Approach, featuring Alex Belser, Ph.D.

PT464 – Bodywork, Somatic Literacy, and Understanding Trauma: The Mind and Body Connection, featuring: Bessel van der Kolk, MD

Fluencetraining.com: Jeffrey Guss, MD

PT290 – Kylea Taylor, M.S., LMFT – Vital Psychedelic Conversations

PT302 – Dr. Adele Lafrance – Vital Psychedelic Conversations

Early Research, Psychedelics in Palliative Care, and the Intersection of Science and the Sacred, featuring: William Richards, STM, Ph.D.

Pathwaysvermont.org: Soteria House

Models of Psychedelic-Assisted Psychotherapy: A Contemporary Assessment and an Introduction to EMBARK, a Transdiagnostic, Trans-Drug Model

Alex Belser_ Ph.D. 2

In this Episode

Alex Belser, Ph.D.

Alex Belser, Ph.D., is a clinical scientist, psychologist, and psychedelic researcher at Yale University and in private practice. His book, EMBARK Psychedelic Therapy for Depression (Oxford University Press), co-authored with Dr. Bill Brennan, offers a clinical guide to working with psychedelic medicines. He has taught in a number of psychedelic training programs about psilocybin, MDMA, ketamine, and DMT therapies. Dr. Belser co-founded the NYU Psychedelic Research Group in 2006 and a non-profit psychedelic center called Nautilus Sanctuary. He served as the Chief Clinical Officer of Cybin, leading clinical teams in the U.S. and Europe. His last book is Queering Psychedelics: From Oppression to Liberation in Psychedelic Medicine. His work has been featured in the media, with coverage in the New York Times, the Atlantic, The Guardian, Forbes, Rolling Stone, NPR, and in Michael Pollan’s book, How to Change Your Mind. Dr. Belser is a teacher of hatha and kundalini yoga. He studied at Georgetown, Cambridge, Columbia, NYU, and Yale. More information is available at centerforbreakthroughs.com.

Socials: Instagram / Facebook / Linkedin

Bill Brennan_ Ph.D.

Bill Brennan, Ph.D.

Bill Brennan, Ph.D., is clinical psychologist, psychedelic researcher, educator, and author in New York City with over two decades of interest and involvement in psychedelic therapy. He has played a variety of roles across several psychedelic clinical trials, including lead trainer, core faculty, curriculum developer, clinical supervisor, and lead author on more than eight treatment manuals. He currently serves as a consultant to Cybin and Gilgamesh, two prominent psychedelic research companies, where he is involved in the development and delivery of their psychedelic treatment approaches. Bill developed the EMBARK model of psychedelic therapy with Dr. Alex Belser, which has been used on four clinical trials to date. He and Dr. Belser authored a comprehensive guide to psychedelic treatment in this approach, entitled EMBARK Psychedelic Therapy for Depression: A New Approach for the Whole Person, published by Oxford University Press. Bill has taught and presented on psychedelic therapy in other contexts, including as a speaker at the 2022 Interdisciplinary Conference for Psychedelic Research, as a lecturer with Psychedelics Today, and as a trainer with Fluence, Naropa University, and other organizations. He serves as an advisory board member for New Yorkers for Mental Health Alternatives, a group that works to expand access to psychedelic medicines, and he has previously served on the ethics working group of the American Psychedelic Practitioners Association.

Socials: Linkedin